Capital Social e Reservas Alterar Data
AstraZeneca USD 47.33B 1.33B 2026-03
Bayer EUR 28.85B 2.9B 2026-03
Essilor EUR 38.89B 1.07B 2025-12
Fresenius EUR 19.77B 1.14B 2025-12
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
GRIFOLS EUR 5.46B 171M 2026-03
Lonza CHF 9.13B 513M 2025-12
Merck EUR 29.74B 1.15B 2026-03
Novartis USD 38.93B 7.2B 2026-03
Philips EUR 11.39B 403M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
Smith & Nephew USD 5.54B 331M 2025-12
Sonova Holding CHF 2.66B 374.5M 2025-06
UCB EUR 10.87B 1.18B 2025-12